Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Trends in Biochemical Sciences|February 5, 2005
Regulation of FoxO activity by CBP/p300-mediated acetylationLars P van der Heide, Marten P SmidtTrends in Molecular Medicine|March 26, 2013
The BCL2 code to dopaminergic development and Parkinson's diseaseLars P van der Heide, Marten P SmidtTrends in Molecular Medicine|June 26, 2024
Boosting endogenous dopamine production: a novel therapeutic approach for Parkinson's diseaseErik H Douma, Marten P Smidt, Lars P van der HeideProgress in Neurobiology|August 19, 2006
Insulin signaling in the central nervous system: learning to surviveLars P van der Heide, Geert M J Ramakers, Marten P SmidtThe Biochemical Journal|March 10, 2004
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulationLars P Van Der Heide, Marco F M Hoekman, Marten P SmidtThe Journal of Biological Chemistry|November 26, 2010
TGFbeta activates mitogen- and stress-activated protein kinase-1 (MSK1) to attenuate cell deathLars P van der Heide, Maarten van Dinther, Aristidis Moustakas, et al.Cancers|July 20, 2021
NUAK1 and NUAK2 Fine-Tune TGF-β SignalingReinofke A J van de Vis, Aristidis Moustakas, Lars P van der HeideTrends in Molecular Medicine|November 11, 2019
MCL1 as a Therapeutic Target in Parkinson's Disease?Edward J Robinson, Sebastian Aguiar, Marten P Smidt, et al.Molecular Cell|November 25, 2010
PARP-1 attenuates Smad-mediated transcriptionPeter Lönn, Lars P van der Heide, Markus Dahl, et al.Journal of Neurochemistry|August 12, 2005
Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent mannerLars P van der Heide, Amer Kamal, Alain Artola, et al.Pageof 3